Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
3 clinical trials · Condition
◉ Watch Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type
| Record | Firm | Date |
|---|---|---|
| Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT02443077) | National Cancer Institute (NCI) | 2016-10-12 |
Track Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type automatically
Every clearance here is in the API, with alerts when new ones post.